SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-014866
Filing Date
2024-02-16
Accepted
2024-02-16 15:47:16
Documents
41
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1223_actavia.htm   iXBRL 10-Q 254739
2 CERTIFICATION f10q1223ex31-1_actavialife.htm EX-31.1 18543
3 CERTIFICATION f10q1223ex32-1_actavialife.htm EX-32.1 6084
  Complete submission text file 0001213900-24-014866.txt   1826848

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE rasp-20231231.xsd EX-101.SCH 23279
5 XBRL CALCULATION FILE rasp-20231231_cal.xml EX-101.CAL 16610
6 XBRL DEFINITION FILE rasp-20231231_def.xml EX-101.DEF 97181
7 XBRL LABEL FILE rasp-20231231_lab.xml EX-101.LAB 200357
8 XBRL PRESENTATION FILE rasp-20231231_pre.xml EX-101.PRE 103523
43 EXTRACTED XBRL INSTANCE DOCUMENT f10q1223_actavia_htm.xml XML 114468
Mailing Address 5 PENN PLAZA, 19TH FLOOR, #1954 NEW YORK NY 10001
Business Address 5 PENN PLAZA, 19TH FLOOR, #1954 NEW YORK NY 10001 646-396-4087
ACTAVIA LIFE SCIENCES, INC. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191083 | Film No.: 24648022
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)